Viewing Study NCT00946361


Ignite Creation Date: 2025-12-24 @ 12:05 PM
Ignite Modification Date: 2025-12-31 @ 6:25 AM
Study NCT ID: NCT00946361
Status: TERMINATED
Last Update Posted: 2015-05-15
First Post: 2009-07-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Impaired Insulin-like Growth Factor-1 (IGF-1) Generation Causes Protein Catabolism and Poor Growth in Children With Crohn Disease
Sponsor: Nationwide Children's Hospital
Organization:

Study Overview

Official Title: Impaired IGF-1 Generation Causes Protein Catabolism and Poor Growth in Children With Crohn Disease
Status: TERMINATED
Status Verified Date: 2009-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: PI left institution
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The investigators will prospectively recruit 26 children with moderate - severe active Crohn disease (PCDAI \>30). Results will be compared to 26 patients in sustained remission (PCDAI \<10 and physician global assessment of remission over the previous 6 months) who are matched for age and gender. Subjects will be studied at baseline and six months. The primary study end-points will be leucine rate of appearance (a measure of protein breakdown) and IGF-1 levels.

This study will test the hypothesis that children with greater disease severity will have worse longitudinal growth and protein catabolism. The investigators will also explore the secondary hypothesis that children with Crohn disease have abnormal IGF-1 generation which is linked to underlying inflammation and disease severity.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: